Multiresistente gramnegative Bakterien

[1]  P. Tamma,et al.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Gatermann,et al.  Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals. , 2016, International journal of medical microbiology : IJMM.

[3]  J. Knobloch,et al.  Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. , 2016, The Journal of antimicrobial chemotherapy.

[4]  S. Karanika,et al.  Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  T. Adam,et al.  Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients , 2015, Annals of Clinical Microbiology and Antimicrobials.

[6]  A. Kramer,et al.  Perioperative Antibiotikaprophylaxe: ein Update , 2015, Krankenhaushygiene up2date.

[7]  M. Bassetti,et al.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. , 2015, The Journal of antimicrobial chemotherapy.

[8]  P. Lipsett,et al.  Trial of short-course antimicrobial therapy for intraabdominal infection. , 2015, The New England journal of medicine.

[9]  A. Kirby,et al.  Antibiotic resistance in Enterobacteriaceae: what impact on the efficacy of antibiotic prophylaxis in colorectal surgery? , 2015, The Journal of hospital infection.

[10]  T. Eckmanns,et al.  Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction. , 2015, Journal of Hospital Infection.

[11]  J. Solomkin,et al.  Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections , 2015, Expert opinion on pharmacotherapy.

[12]  C. Eckmann.  Antibiotikatherapie intraabdomineller Infektionen im Zeitalter der Multiresistenz , 2015, Der Chirurg.

[13]  V. Miriagou,et al.  Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems , 2014, Antimicrobial Agents and Chemotherapy.

[14]  E. Larson,et al.  Risk factors for extended spectrum β-lactamase-producing Escherichia coli versus susceptible E. coli in surgical site infections among cancer patients in Mexico. , 2014, Surgical infections.

[15]  C. Landersdorfer,et al.  Combination therapy for carbapenem-resistant Gram-negative bacteria , 2013, Expert review of anti-infective therapy.

[16]  Krinko.  Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheits- erregern mit speziellen Resistenzen und Multiresistenzen , 2013 .

[17]  E. P. Dellinger,et al.  Clinical practice guidelines for antimicrobial prophylaxis in surgery. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[18]  Krinko.  Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen , 2012 .

[19]  M. Bassetti,et al.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  H. Rohde,et al.  Emergence of carbapenemases in Gram-negative bacteria in Hamburg, Germany. , 2011, Diagnostic microbiology and infectious disease.

[21]  A. Glenny,et al.  Antimicrobial prophylaxis for colorectal surgery. , 2014, The Cochrane database of systematic reviews.

[22]  B. Davis,et al.  Interrupted Time Series Analysis of Vancomycin Compared to Cefuroxime for Surgical Prophylaxis in Patients Undergoing Cardiac Surgery , 2007, Antimicrobial Agents and Chemotherapy.

[23]  Y. Carmeli,et al.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[24]  M. Amrani,et al.  Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial , 2007, Heart.

[25]  K. Itani,et al.  Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. , 2006, The New England journal of medicine.

[26]  J. Roxburgh,et al.  Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. , 2005, Journal of Hospital Infection.